Insulin Delivery Devices Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar. Hyperglycemia, or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body's systems, especially the nerves and blood vessels.

The rising diabetic population, obesity, and sedentary lifestyle are some of the major factors driving this market's rise. In addition, advancements in human insulin delivery systems, innovations in insulin delivery system techniques, and healthy reimbursement policies, rising awareness among the population about diabetes control and accessibility to insulin delivery systems, and rising awareness among the population about diabetes control and accessibility to insulin delivery systems are all factors ensuring the growth of the insulin delivery devices market. The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.

Request Sample Copy of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=17773

According to UnivDatos Market Insights (UMI)’ research report “Insulin Delivery Devices Market”, the market is expected to witness a CAGR growth of around ~10% during the forecast period 2021-2027F. Global Insulin Delivery Devices Market is experiencing significant owing to growth in diabetic population, aging, urbanization, and increasing prevalence of obesity and physical inactivity. In addition, advancements in human insulin delivery systems, innovations in insulin delivery system techniques, and healthy reimbursement policies, rising awareness among the population about diabetes control and accessibility to insulin delivery systems, and rising awareness among the population about diabetes.

Based on Type, the market is segmented into Insulin Pens (Reusable, Disposable), Insulin Pumps (External, Tethered, Patch), Insulin Syringes, Insulin Jet Injectors and Other Devices. The Insulin Pens segment leads the Insulin Delivery Devices Market. Insulin pens are growing in popularity, and many people with diabetes nowadays use a pen to administer insulin as it allows more simple, accurate, and convenient delivery than using a vial and syringe.

Based on End-User, the Insulin Delivery Devices market is segmented into Patients/Homecare and Hospitals & Clinics. The patients/homecare segment commanded the largest share of the insulin delivery devices market and is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing diabetic population and rising healthcare expenditure.

Request Sample Copy of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=17773

North America to Grab Lion’s Share

North America currently owns the maximum market share in the Insulin Delivery Devices market. The market was dominated by North America. The rising prevalence of diabetes and favourable reimbursement scenario in the United States and Canada, growing venture capital investments and IPOs in the United States, and FDA approvals to increase the commercial availability of insulin delivery devices in the United States all contribute to this region's large share. However, Asia-Pacific region is expected to grow with the highest CAGR over the forecast period.

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Insulin Delivery Devices Market are includes Medtronic, Becton, Dickinson and Company, Novo Nordisk, Eli Lilly and Company, Sanofi, Insulet Corporation, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Animas Corporation, Biocon Ltd, etc.

• In July 2020; Medtronic plc and Tandem Diabetes Care, Inc. announced that they have entered into a non-exclusive patent cross-license agreement for certain technologies in the field of diabetes. Cross licensing each other’s patent portfolios enables both companies to focus on helping people with diabetes through innovation of future products and services, while avoiding the distraction of potential legal disagreements.

“Insulin Delivery Devices Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of go to market strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us - https://univdatos.com/report/insulin-delivery-devices-market/

Market Segmentation:

1. By Type [Insulin Pens (Reusable, Disposable), Insulin Pumps (External, Tethered, Patch), Insulin Syringes, Insulin Jet Injectors, Other Devices]
2. By End-User (Patients/Homecare, Hospitals & Clinics)
3. By Region [North America (United States, Canada, Rest of North America), Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), and Rest of World)]
4. By Company (Medtronic, Becton, Dickinson and Company, Novo Nordisk, Eli Lilly and Company, Sanofi, Insulet Corporation, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Animas Corporation, Biocon Ltd)

Key questions answered in the study:

1. What are the current and future trends of the Insulin Delivery Devices Sector?
2. How the industry has been evolving in terms of consumer demand and product category?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Insulin Delivery Devices Sector?
5. What is the customer orientation, purchase behavior, and expectations from the Insulin Delivery Devices suppliers across various countries?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 INSULIN DELIVERY DEVICES MARKET COVID-19 IMPACT

6 INSULIN DELIVERY DEVICES MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY TYPE

8 MARKET INSIGHTS BY END-USER

9 MARKET INSIGHTS BY REGION

10 INSULIN DELIVERY DEVICES MARKET DYNAMICS

11 INSULIN DELIVERY DEVICES MARKET OPPORTUNITIES

12 INSULIN DELIVERY DEVICES MARKET TRENDS

13 INSULIN DELIVERY DEVICES & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

17 COMPANY PROFILED

18 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

• Virtual Healthcare Delivery Market to Reach US$ 122 Billion by 2027 Globally |CAGR: 24.6%| 
• Preventive Healthcare Technologies and Services Market to Reach US$ 493.1 Billion by 2027 Globally |CAGR: 10.5%| 
• Internet of Medical Things Market to Reach US$ 284.5 Billion by 2027 Globally | CAGR: 18.5% |
• Healthcare Analytics Market to Reach US$ 118.2 Billion by 2027 Globally |CAGR: 31%|